Kıvrak, H. Et Al. 2022. HER2 Amplification by Next-Generation Sequencing in Lung Carcinoma: A Comparison of NGS Amplified and Non-amplified Cases by Immunohistochemistry and In Situ Hybridization. Balkan Medical Journal , vol.39, no.1 , 21-29.

Kıvrak, H., Özakıncı, H., Karasoy, D., & Dizbay Sak, S., (2022). HER2 Amplification by Next-Generation Sequencing in Lung Carcinoma: A Comparison of NGS Amplified and Non-amplified Cases by Immunohistochemistry and In Situ Hybridization. Balkan Medical Journal , vol.39, no.1, 21-29.

Kıvrak, HALE Et Al. "HER2 Amplification by Next-Generation Sequencing in Lung Carcinoma: A Comparison of NGS Amplified and Non-amplified Cases by Immunohistochemistry and In Situ Hybridization," Balkan Medical Journal , vol.39, no.1, 21-29, 2022

Kıvrak, HALE Et Al. "HER2 Amplification by Next-Generation Sequencing in Lung Carcinoma: A Comparison of NGS Amplified and Non-amplified Cases by Immunohistochemistry and In Situ Hybridization." Balkan Medical Journal , vol.39, no.1, pp.21-29, 2022

Kıvrak, H. Et Al. (2022) . "HER2 Amplification by Next-Generation Sequencing in Lung Carcinoma: A Comparison of NGS Amplified and Non-amplified Cases by Immunohistochemistry and In Situ Hybridization." Balkan Medical Journal , vol.39, no.1, pp.21-29.

@article{article, author={HALE KIVRAK Et Al. }, title={HER2 Amplification by Next-Generation Sequencing in Lung Carcinoma: A Comparison of NGS Amplified and Non-amplified Cases by Immunohistochemistry and In Situ Hybridization}, journal={Balkan Medical Journal}, year=2022, pages={21-29} }